Anyone attending the JP Morgan Healthcare Conference in San Francisco from January 7 to January 11, 2017 or any of the other concurrent medical conferences in the Union Square Financial District during the second week of the New Year is invited to meet the CEO while he is there to learn about BioSculpture Technology’s Endoscopic Visceral Lipectomy solution to the burgeoning Obesity and Type 2 Diabetes problem.
Please contact Pascal Nigen ([email protected]) to arrange a one-on-one meeting.
Since BioSculpture Technology, Inc.’s founding in 2001, our equipment has always been manufactured and assembled in the U.S.A. Of course we happily use components from our allies around the world and will continue to do so when those components help us make our devices better. But, we have never opted for a foreign component merely because of cost. Our standard, the American standard, has been that of making the best possible product, and manufacturing it inside the U.S.A.
Last night the “silent majority” spoke and reclaimed our country back for everyone who actually works for a living or who wants to again be able to work for a living. U.S. workers expressed their desire to be able to ply their trades again and reawaken the American dream. And, it was a beautiful thing. Read more
BST now has numerous pipeline products under development and 21 pending international andU.S.patent applications with claims relating to:
You can view BST product offerings, read a white paper discussing clinical results, a surgical video of them in use, and illustrative animations of twin cannula reciprocation and the Airbrush(R) Liposculptor II on the company website.
BST has engaged the Maxim Group as its investment banker to make a private placement of $10 Million Dollars its equity for the company’s expansion.
